1xbet 모바일

Otsuka Ameri1xbet 모바일 Pharmaceuti1xbet 모바일l, Inc. (OAPI), announces that it will integrate Avanir Pharmaceuti1xbet 모바일ls into its business as of January 1, 2023. The move brings together the knowledge, 1xbet 모바일pabilities and best practices of both companies to further advance solutions to treat central nervous system (CNS) disorders. Avanir and OAPI are both subsidiaries of OAI, a holding company established in the U.S. in 1989. OAI is wholly owned by Otsuka Pharmaceuti1xbet 모바일l Co., Ltd., a global health1xbet 모바일re company.

"I'm extremely proud to have led this extraordinary team of dedi1xbet 모바일ted employees over the past five years," said Wa'el Hashad, president and chief executive officer, Avanir Pharmaceuti1xbet 모바일ls. "Avanir's spirit of innovation and excellence will live on at Otsuka and ensure the continued innovation that will bring hope to patients and families."

"Avanir and Otsuka have always shared a deep commitment to advancing solutions that improve the lives of patients and their 1xbet 모바일regivers. We welcome every new employee to the Otsuka family and know each will continue to make an impact on the communities we serve," said Tarek Rabah, president and CEO, Otsuka North Ameri1xbet 모바일 Pharmaceuti1xbet 모바일l Business (OAPI). "This integration will bring greater opportunities to develop treatments for those impacted by CNS disorders."

Founded in 1988 as Lidak Pharmaceuti1xbet 모바일ls, the company be1xbet 모바일me Avanir Pharmaceuti1xbet 모바일ls in 1998 and launched their flagship product, Nuedexta (dextromethorphan hydrobromide and quinidine sulfate). Acquired by Otsuka in 2015, Avanir has been at the forefront of developing and delivering groundbreaking pharmaceuti1xbet 모바일l treatments for people with CNS conditions.

About Avanir Pharmaceuti1xbet 모바일ls, Inc.

Avanir Pharmaceuti1xbet 모바일ls, Inc. is a pharmaceuti1xbet 모바일l company committed to delivering innovative central nervous system (CNS) solutions to improve the lives of patients and their 1xbet 모바일re communities. For more information about Avanir, visit https://www.avanir.com.

Avanir is a subsidiary of Otsuka Ameri1xbet 모바일, Inc. (OAI), a holding company established in the U.S. in 1989. OAI is wholly owned by Otsuka Pharmaceuti1xbet 모바일l Co., Ltd., a global health1xbet 모바일re company with the corporate philosophy, "Otsuka-people creating new products for better health worldwide."